EUVIMEDEUVIMED entdecken
Vergleichsstudie

Dosimetric Comparison of Brain Sparing Between HyperArc and GammaKnife for Single to Triple Brain Metastases

Yoshihiro Ueda, Kanji Mori, Shingo Ohira, Kazuo Tarutani, Naoyuki Kanayama, Ayako Okamura, Koji Konishi

Anticancer Research · 2025

DOI: 10.21873/anticanres.17544 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Anticancer Research, 2025. Verfasst von Yoshihiro Ueda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan; uedetu@gmail.com. Hauptthemen laut MEDLINE: Brain Neoplasms, Radiosurgery, Radiotherapy, Intensity-Modulated, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: A novel linac-bases radiosurgery (SRS) system, HyperArc, applied to the non-coplanar volume-modulated arc therapy (VMAT) technique, was developed and released in clinical practice. The aim of the study was to evaluate the dosimetric performance of brain sparing in single-target to three-target cases, for two types of SRS systems: GammaKnife and HyperArc. PATIENTS AND METHODS: A total of 83 patients treated with GammaKnife SRS (35 with single, 24 with double, and 24 with triple metastases) were retrospectively analyzed. Treatment plans were recalculated using HyperArc. Dosimetric parameters, including conformity index (CI), gradient index (GI), and brain volume receiving 2-20 Gy (V2-V20), were compared between the two systems. RESULTS: No significant difference in D99 of the planning target volume (PTV) was observed between GammaKnife and HyperArc. HyperArc exhibited superior CI100, with values approaching 1.0. V4-V20 for the whole brain minus PTV were significantly lower for HyperArc than GammaKnife. In single-target cases, GI was significantly lower for HyperArc, while in triple-target cases, it was higher. V12 volumes for HyperArc were comparable to those for GammaKnife, even in cases with volumes

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsRadiosurgeryRadiotherapy, Intensity-ModulatedBrainHumansMaleRadiotherapy Planning, Computer-AssistedRetrospective StudiesFemaleRadiotherapy DosageMiddle AgedAgedAdult

Stichwörter der Autor:innen

GammaKnifeHyperArcbrain metastasisbrain sparing

Autor:innen und Institutionen

  • Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan; uedetu@gmail.com.
  • Department of Neurosurgery, Kansai Rosai Hospital, Amagasaki, Japan.
  • Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Radiation Oncology, Kansai Rosai Hospital, Amagasaki, Japan.

Zitieren

APA

Ueda, Y., Mori, K., Ohira, S., Tarutani, K., Kanayama, N., Okamura, A., & Konishi, K. (2025). Dosimetric Comparison of Brain Sparing Between HyperArc and GammaKnife for Single to Triple Brain Metastases. Anticancer Research. https://doi.org/10.21873/anticanres.17544

Vancouver

Ueda Y, Mori K, Ohira S, Tarutani K, Kanayama N, Okamura A, et al. Dosimetric Comparison of Brain Sparing Between HyperArc and GammaKnife for Single to Triple Brain Metastases. Anticancer Research. 2025. doi:10.21873/anticanres.17544

BibTeX
@article{Ueda2025,
  author = {Ueda, Yoshihiro and Mori, Kanji and Ohira, Shingo and Tarutani, Kazuo and Kanayama, Naoyuki and Okamura, Ayako and Konishi, Koji},
  title = {Dosimetric Comparison of Brain Sparing Between HyperArc and GammaKnife for Single to Triple Brain Metastases},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17544}
}
Kostenlos starten →